Paul A. Cossum - Concepedia

Author

Paul A. Cossum

Also Known As

Cossum, Paul Adrian, P A Cossum, P A. COSSUM, P Cossum, P. A. COSSUM, P. A. Cossum, P. COSSUM, P. Cossum, P.A. Cossum, PAUL A. COSSUM

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of Tasmania Plex Pharmaceuticals (United States)University of British Columbia Kaiser Permanente Columbia University

About

Paul A. Cossum is an author at University of Tasmania specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	828
2	Health Sciences	2	2	30
3	Education	1	1	13
4	Engineering	1	1	18
5	Natural Sciences	1	1	114

Paul A. Cossum

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats. Paul A. Cossum, Henri Sasmor, D Dellinger, Journal of Pharmacology and Experimental Therapeutics	1993	266
Biological properties of a CD4 immunoadhesin Randal A. Byrn, Joyce Mordenti, Catherine Lucas, Nature Autoimmune DiseaseImmunologyAntigen ProcessingAutoimmunityImmunochemistry	1990	175
Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity. Irina V. Lebedeva, Robert F. Rando, Joshua O. Ojwang, PubMed UrologyAntiapoptotic MembersChemoprevention StrategyOligonucleotide TreatmentMedicine	2000	171
Intramolecular G-quartet Motifs Confer Nuclease Resistance to a Potent Anti-HIV Oligonucleotide Jeffrey S. Bishop, Judith K. Guy-Caffey, Joshua O. Ojwang, Journal of Biological Chemistry	1996	114
Identification and characterization of binding proteins for inhibin and activin in human serum and follicular fluids. Lynne Krummen, Teresa K. Woodruff, G DeGuzman, Endocrinology Protein SecretionFollicular FluidsImmunologyInflammationBioanalysis	1993	114
Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats. Paul A. Cossum, L Truong, Scott R. Owens, Journal of Pharmacology and Experimental Therapeutics	1994	110
In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole Alfonso Javier Carrillo‐Muñoz, Guillermo Quindós, Cristina Tur Tur, Journal of Antimicrobial Chemotherapy	1999	84
Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice T L Wallace, Victor L. Paetznick, Paul A. Cossum, Antimicrobial Agents and Chemotherapy Aspergillus Fumigatus InfectionLiposomal NystatinAntifungal AgentFungal Cell BiologyAntifungal Agents	1997	64
LOSS OF NITROGLYCERIN FROM INTRAVENOUS INFUSION SETS Paul A. Cossum, Michael S. Roberts, Andrew Galbraith, The Lancet ThrombosisCardiovascular DiseaseMedicineCardiologyVascular Biology	1978	62
The availability of nitroglycerin from parenteral solutions Michael S. Roberts, Paul A. Cossum, Andrew Galbraith, Journal of Pharmacy and Pharmacology	1980	45

Page 1